Brii Biosciences

Brii Biosciences

CA - San Mateo
Biotechnology1 H-1B visas (FY2023)
WebsiteLinkedInCareers Page

Focus: SIRNA, Biologics, Monoclonal Antibodies, Small Molecules

Brii Biosciences is a life sciences company focused on SIRNA, Biologics, Monoclonal Antibodies, Small Molecules.

Gene Therapy
Funding Stage
PUBLIC
Open Jobs
0

Pipeline & Clinical Trials

BRII-198
COVID-19
Phase 1
Clinical Trials (1)
NCT04479644Safety, Tolerability, and Pharmacokinetics Study of Human Monoclonal Antibody BRII-198
Phase 1
BRII-196 and BRII-198
COVID-19
Phase 1
Clinical Trials (1)
NCT04691180A Phase 1 Study of Human Monoclonal Antibodies, BRII-196 and BRII-198
Phase 1
BRII-196
COVID-19
Phase 1
Clinical Trials (1)
NCT04479631Safety, Tolerability, and Pharmacokinetics Study of Human Monoclonal Antibody BRII-196
Phase 1
Phase 1
Clinical Trials (1)
NCT05845840A Study of BRII-297 in Healthy Adult Subjects
Phase 1
Phase 2
Phase 2
Phase 2
Phase 2
Clinical Trials (1)
NCT06650852A Study to Evaluate the Efficacy and Safety of Combination Therapy of BRII-179, BRII-835 and PEG-IFNα in Participants With Chronic Hepatitis B Virus (HBV) Infection (ENHANCE)
Phase 2
Phase 2
Clinical Trials (1)
NCT06057012A Study of BRII-296 in Adults With Severe Postpartum Depression (PPD)
Phase 2
Phase 2
BRII-196 and BRII-198
COVID-19
Phase 2
Clinical Trials (1)
NCT04770467A Safety and Efficacy Study of Human Monoclonal Antibodies, BRII-196 and BRII-198 for the Treatment of Patients With COVID-19
Phase 2
BRII-196 and BRII-198
COVID-19
Phase 2
Clinical Trials (1)
NCT04787211A Study of Human Monoclonal Antibodies, BRII-196 and BRII-198
Phase 2
bamlanivimab 7000mg
Coronavirus
Phase 2/3
BRII-196
COVID-19
Phase 3
Clinical Trials (1)
NCT05780424BRII-196/BRII-198 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)
Phase 3
LY3819253
Covid19
Phase 3

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts
Portfolio: 9 clinical trials
H-1B (2023): 1 approval
Publications: 21 in PubMed

Visa Sponsorship

Sponsors Work Visas
H-1B Petitions (FY2023)
1
Approved
0
Denied
100%
Rate

Source: USCIS H-1B Employer Data Hub